Drug: |
Nilotinib or Imatinib |
|||
---|---|---|---|---|
Trial: |
Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients (ENESTg1) |
|||
Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Completed |
Mount Sinai Hospital600 University Ave. |
Principal Investigator: |
Martin Blackstein, MD |
---|---|
Contact: |
Martin Blackstein, MD 011-416-586-5371 |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Mount Sinai Hospital Website: |
http://www.mountsinai.on.ca/ |
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.